URGN

URGN Change in Working Capital

-$86.42MTTM · USD

Period ending:

URGN FY Change in Working CapitalUSD
URGN FY Change in Working Capital2013-12-31: $13.00K2014-12-31: -$162.00K2015-12-31: $609.00K2016-12-31: $1.21M2017-12-31: $3.76M2018-12-31: $7.16M2019-12-31: $4.32M2020-12-31: -$6.37M2021-12-31: -$13.11M2022-12-31: -$6.31M2023-12-31: $3.34M2024-12-31: $4.93M2025-12-31: -$27.91M$7.16M-$27.91M
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

URGN change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Urogen Pharma Ltd Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-27,914,000
4,933,000
3,336,000
-6,306,000
-13,106,000
-6,369,000
4,320,000
7,164,000
3,757,000
1,210,000
609,000
-162,000
13,000

Compare change in working capital

All URGN financial metrics · URGN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.